FDAnews Device Daily Bulletin

REVIEWERS CITE FLAWS AT GUIDANT

March 23, 2006
A A

An expert panel commissioned last summer by the Guidant Corporation to review its handling of heart device flaws said yesterday that the company had systematically failed to fully assess patient safety in deciding whether to publicize product failures.

The New York Times (http://www.nytimes.com/2006/03/21/business/21guidant.html?_r=1&oref=slogin)